GlassScriptPhysician profile
Katherine J Durham
NPI 1275757437
$1,640.12
in general payments reported to CMS, 2019-2025
23 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $242 · 2021: $44.11 · 2022: $56.45 · 2023: $412 · 2024: $120 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $384.44 | 2019-2025 | |
| Amgen INC. | $258.09 | 2019-2020 | |
| Medtronic, INC. | $106.38 | 2021-2023 | Linq II, Cobalt Dr Mri Surescan, Selectsecure |
| Shockwave Medical, INC | $105.99 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $99.12 | 2019-2025 | |
| Philips North America LLC | $98.63 | 2020-2025 | Extended Holter |
| Janssen Pharmaceuticals, INC | $80.44 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $75.94 | 2020-2025 | Eliquis, Camzyos |
| Baxter Healthcare | $71.55 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Irhythm Technologies, INC. | $48.72 | 2020-2023 | Zio Xt Patch |
| Merck Sharp & Dohme LLC | $40.94 | 2023 | Verquvo |
| Novo Nordisk INC | $37.54 | 2024 | Wegovy |
| Braemar Manufacturing, LLC | $35.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.46 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.17 | 2025 | Lifevest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $24.74 | 2019 | |
| Abbott Laboratories | $18.83 | 2022 | |
| Cardiovascular Systems INC. | $17.37 | 2019 | |
| Ge Healthcare | $17.23 | 2022 | |
| Boston Scientific Corporation | $16.84 | 2019 | |
| Silk Road Medical, INC. | $15.49 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bridgebio Pharma, INC. | $14.60 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $14.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Durham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.